Characterization of Skin and Facial Fat Pad Thickness Changes Following Microneedling Radiofrequency With and Without Topical Poly-L-Lactic Acid for Facial Rejuvenation

Inclusion Criteria: * Seeking facial rejuvenation for cosmetic concerns * Able and willing to provide informed consent * Willing to comply with study procedures and follow-up visits Exclusion Criteria: * Prior filler injection or energy-based device treatment to the face within the past 6 months * Previous facial surgeries * Pregnant or breastfeeding * Active infection, dermatitis, or open lesions in the treatment area * History of keloids or abnormal scarring * Known allergy to poly-L-lactic acid (PLLA)- Current participation in another clinical trial involving facial aesthetic treatments * Presence of pre-cancerous or cancerous lesions in the treatment area * Current or planned use of glucagon-like peptide-1 receptor agonists (e.g., Ozempic, semaglutide) during the study period. Subjects on these medications will be excluded due to potential effects on facial fat and overall weight. * HIV+ patients * Patients on HIV medications- Patients that have eczema and rosacea